Anbio Biotechnology Stock Forward View - Simple Exponential Smoothing
| NNNN Stock | 21.09 0.82 3.74% |
Anbio Stock outlook is based on your current time horizon. Although Anbio Biotechnology's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Anbio Biotechnology's systematic risk associated with finding meaningful patterns of Anbio Biotechnology fundamentals over time.
As of today, the RSI of Anbio Biotechnology's share price is approaching 44. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Anbio Biotechnology, making its price go up or down. Momentum 44
Sell Extended
Oversold | Overbought |
Quarterly Earnings Growth 0.028 | Quarterly Revenue Growth (0.22) |
Using Anbio Biotechnology hype-based prediction, you can estimate the value of Anbio Biotechnology Class from the perspective of Anbio Biotechnology response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Exponential Smoothing forecasted value of Anbio Biotechnology Class on the next trading day is expected to be 21.09 with a mean absolute deviation of 2.32 and the sum of the absolute errors of 139.27. Anbio Biotechnology after-hype prediction price | USD 18.92 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Anbio Biotechnology to cross-verify your projections. Anbio Biotechnology Additional Predictive Modules
Most predictive techniques to examine Anbio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Anbio using various technical indicators. When you analyze Anbio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Anbio Biotechnology Simple Exponential Smoothing Price Forecast For the 3rd of February
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Anbio Biotechnology Class on the next trading day is expected to be 21.09 with a mean absolute deviation of 2.32, mean absolute percentage error of 8.93, and the sum of the absolute errors of 139.27.Please note that although there have been many attempts to predict Anbio Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Anbio Biotechnology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Anbio Biotechnology Stock Forecast Pattern
| Backtest Anbio Biotechnology | Anbio Biotechnology Price Prediction | Research Analysis |
Anbio Biotechnology Forecasted Value
In the context of forecasting Anbio Biotechnology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Anbio Biotechnology's downside and upside margins for the forecasting period are 7.90 and 34.28, respectively. We have considered Anbio Biotechnology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Anbio Biotechnology stock data series using in forecasting. Note that when a statistical model is used to represent Anbio Biotechnology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.462 |
| Bias | Arithmetic mean of the errors | 0.0152 |
| MAD | Mean absolute deviation | 2.3212 |
| MAPE | Mean absolute percentage error | 0.0821 |
| SAE | Sum of the absolute errors | 139.27 |
Predictive Modules for Anbio Biotechnology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Anbio Biotechnology Class. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Anbio Biotechnology After-Hype Price Density Analysis
As far as predicting the price of Anbio Biotechnology at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Anbio Biotechnology or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Anbio Biotechnology, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Anbio Biotechnology Estimiated After-Hype Price Volatility
In the context of predicting Anbio Biotechnology's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Anbio Biotechnology's historical news coverage. Anbio Biotechnology's after-hype downside and upside margins for the prediction period are 5.73 and 32.11, respectively. We have considered Anbio Biotechnology's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Anbio Biotechnology is slightly risky at this time. Analysis and calculation of next after-hype price of Anbio Biotechnology Class is based on 3 months time horizon.
Anbio Biotechnology Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Anbio Biotechnology is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Anbio Biotechnology backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Anbio Biotechnology, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.44 | 13.19 | 2.17 | 0.22 | 3 Events / Month | 3 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
21.09 | 18.92 | 10.29 |
|
Anbio Biotechnology Hype Timeline
Anbio Biotechnology Class is now traded for 21.09. The entity has historical hype elasticity of -2.17, and average elasticity to hype of competition of -0.22. Anbio is estimated to decline in value after the next headline, with the price expected to drop to 18.92. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -10.29%, whereas the daily expected return is now at 1.44%. The volatility of related hype on Anbio Biotechnology is about 8549.07%, with the expected price after the next announcement by competition of 20.87. The company had not issued any dividends in recent years. Given the investment horizon of 90 days the next estimated press release will be in about 3 days. Check out Historical Fundamental Analysis of Anbio Biotechnology to cross-verify your projections.Anbio Biotechnology Related Hype Analysis
Having access to credible news sources related to Anbio Biotechnology's direct competition is more important than ever and may enhance your ability to predict Anbio Biotechnology's future price movements. Getting to know how Anbio Biotechnology's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Anbio Biotechnology may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| GXRFF | Prospera Energy | 0.00 | 0 per month | 0.00 | (0.03) | 10.70 | (9.67) | 38.06 | |
| USSTX | Tax Exempt Short Term | 2.28 | 4 per month | 0.00 | (0.39) | 0.19 | (0.10) | 0.39 | |
| JDDSF | JD Sports Fashion | (2.61) | 7 per month | 0.00 | (0.11) | 0.00 | (0.87) | 22.36 | |
| NEMTF | Nemetschek SE | 0.00 | 0 per month | 0.00 | (0.14) | 0.00 | 0.00 | 33.70 | |
| AA | Alcoa Corp | 1.42 | 8 per month | 2.69 | 0.16 | 6.40 | (5.54) | 14.55 | |
| JDSPY | JD Sports Fashion | (2.61) | 11 per month | 0.00 | (0.06) | 6.19 | (6.25) | 15.07 | |
| ALLE | Allegion PLC | 0.44 | 9 per month | 0.00 | (0.07) | 2.15 | (1.99) | 5.10 |
Other Forecasting Options for Anbio Biotechnology
For every potential investor in Anbio, whether a beginner or expert, Anbio Biotechnology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Anbio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Anbio. Basic forecasting techniques help filter out the noise by identifying Anbio Biotechnology's price trends.Anbio Biotechnology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anbio Biotechnology stock to make a market-neutral strategy. Peer analysis of Anbio Biotechnology could also be used in its relative valuation, which is a method of valuing Anbio Biotechnology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Anbio Biotechnology Market Strength Events
Market strength indicators help investors to evaluate how Anbio Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Anbio Biotechnology shares will generate the highest return on investment. By undertsting and applying Anbio Biotechnology stock market strength indicators, traders can identify Anbio Biotechnology Class entry and exit signals to maximize returns.
Anbio Biotechnology Risk Indicators
The analysis of Anbio Biotechnology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Anbio Biotechnology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting anbio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 9.48 | |||
| Semi Deviation | 10.7 | |||
| Standard Deviation | 13.62 | |||
| Variance | 185.62 | |||
| Downside Variance | 122.28 | |||
| Semi Variance | 114.56 | |||
| Expected Short fall | (10.79) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Anbio Biotechnology
The number of cover stories for Anbio Biotechnology depends on current market conditions and Anbio Biotechnology's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Anbio Biotechnology is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Anbio Biotechnology's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Anbio Biotechnology Short Properties
Anbio Biotechnology's future price predictability will typically decrease when Anbio Biotechnology's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Anbio Biotechnology Class often depends not only on the future outlook of the potential Anbio Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Anbio Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 42.3 M | |
| Cash And Short Term Investments | 11.8 M |
Check out Historical Fundamental Analysis of Anbio Biotechnology to cross-verify your projections. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Will Biotechnology sector continue expanding? Could Anbio diversify its offerings? Factors like these will boost the valuation of Anbio Biotechnology. Anticipated expansion of Anbio directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Anbio Biotechnology data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.028 | Earnings Share 0.06 | Revenue Per Share | Quarterly Revenue Growth (0.22) | Return On Assets |
Understanding Anbio Biotechnology Class requires distinguishing between market price and book value, where the latter reflects Anbio's accounting equity. The concept of intrinsic value—what Anbio Biotechnology's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Anbio Biotechnology's price substantially above or below its fundamental value.
It's important to distinguish between Anbio Biotechnology's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Anbio Biotechnology should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Anbio Biotechnology's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.